China’s benchmark Shanghai Composite Index (000001.SH) lost 0.64% on Friday, while the Shenzhen Component Index (399001.SZ) rose 0.25%.
Shanghai’s tech-heavy STAR 50 Index (000688.SH) gained 0.19% for the day, while Shenzhen’s similar ChiNext Index (399006.SZ) rose 0.38%.
Below is a rundown of the top China business and finance stories, plus other news for the day:
· Weekly Must-Read: Why China’s Bond Traders Got Cut Off From the Data They Needed
Financial regulators stood at the center of last week’s tumultuous suspension of services that provide crucial price information to traders
· China Issues Final Rules for Overhaul of $3 Trillion Trust Industry
Regulations aimed at wringing out risk and imposing tougher oversight on a troubled industry take effect June 1
· South Korea’s Hanwha Wins Three More Approvals for Daewoo Shipbuilding Deal
China, Singapore and Vietnam join Britain, Japan and Turkey in clearing $1.53 billion takeover, leaving only South Korea and EU decisions up in the air
· Anti-Graft Crackdown Ensnares State Energy Giants
Corruption probes hit five executives from several enterprises as graft busters expand investigations across multiple sectors
· Chinese Police Arrest Multiple Pro Soccer Players
Shandong Taishan midfielder Jin Jingdao is among those taken into custody March 17 amid speculation of a broadening corruption probe
· Chinese Man Exonerated After Record 29 Years of Wrongful Imprisonment
Tan Xiuyi, now 68, is seeking compensation of $2.56 million after his name was cleared for the murder of a family of three
· In Depth: Why a Sperm Bank Drive Is Fueling Fears of Infertility in China
A nationwide campaign for donations has triggered speculation online about the causes. But insiders say a more complicated picture exists and that sperm banks can play a bigger role to address the declining national birthrate
· Lithium Prices Nosedive Amid Weaker Demand
Key material for EV batteries drops by half since November as end to China’s subsidies slams demand for electric vehicles
· China Clears First Homegrown mRNA Covid Vaccine
CSPC Pharmaceutical reports winning approval from National Medical Products Administration for shot targeting omicron variant
· China Huarong Expects to Post $4 Billion Loss for 2022
Red ink reflects restructuring amid government bailout as well as falling asset values from capital market volatility and real estate slump
Click here to read more of the latest news.
This article was generated by Caixin Automation.
Follow the Chinese markets in real time with Caixin Global’s new stock database.
